These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1686352)

  • 81. Splenic lymphoma with villous lymphocytes (SLVL) responding to 2-chlorodeoxyadenosine (2-CdA).
    Virchis A; Mehta A
    Br J Haematol; 1998 Mar; 100(3):609. PubMed ID: 9504654
    [No Abstract]   [Full Text] [Related]  

  • 82. Interferons: current status and future directions of this prototypic biological.
    Smalley RV; Borden EC
    Springer Semin Immunopathol; 1986; 9(1):73-83. PubMed ID: 2425443
    [No Abstract]   [Full Text] [Related]  

  • 83. Deficient natural killer (NK) cell activity in paroxysmal nocturnal haemoglobinuria (PNH).
    Yoda Y; Abe T; Mitamura K; Saito K; Kawada K; Onozawa Y; Adachi Y; Nomura T
    Br J Haematol; 1982 Dec; 52(4):559-62. PubMed ID: 7138786
    [No Abstract]   [Full Text] [Related]  

  • 84. [The activity of natural killers and K cells and their interferon sensitivity in subjects inoculated against diphtheria and meningococcal infection].
    Pchelintsev SIu; Solokhin EV; Riazantsev SV; Savel'ev AP; Romanov VA; Vasilenko AZh; Tsintsadze AG; Stepanov AV; Denisov LA; Afanas'ev SS
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (1):51-5. PubMed ID: 8184614
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Metabolism and action of purine nucleoside analogs.
    Plunkett W; Saunders PP
    Pharmacol Ther; 1991; 49(3):239-68. PubMed ID: 1675805
    [TBL] [Abstract][Full Text] [Related]  

  • 86. In vitro stimulation of human NK activity by an estrogen antagonist (tamoxifen).
    Mandeville R; Ghali SS; Chausseau JP
    Eur J Cancer Clin Oncol; 1984 Jul; 20(7):983-5. PubMed ID: 6611266
    [No Abstract]   [Full Text] [Related]  

  • 87. From the Food and Drug Administration.
    Nightingale SL
    JAMA; 1992 May; 267(18):2445. PubMed ID: 1349355
    [No Abstract]   [Full Text] [Related]  

  • 88. Tumor lysis syndrome after treatment of chronic lymphocytic leukemia with cladribine.
    Trendle MC; Tefferi A
    N Engl J Med; 1994 Apr; 330(15):1090. PubMed ID: 8127350
    [No Abstract]   [Full Text] [Related]  

  • 89. Chemotherapeutic agents and modulation of natural killer cell activity in vitro.
    Charamella LJ; Meyer C; Thompson GE; Dimitrov NV
    J Immunopharmacol; 1985; 7(1):53-65. PubMed ID: 4008941
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Increase of NK cell-mediated cytotoxicity of hairy cell leukemia patients after splenectomy.
    Bigda J; Myśliwska J; Baran V; Zoltowska A; Hellmann A
    Eur J Haematol; 1989 Jul; 43(1):78-9. PubMed ID: 2767244
    [No Abstract]   [Full Text] [Related]  

  • 91. Cytotoxic effector mechanisms in AIDS.
    Cunningham-Rundles S; Metroka CE; Safai B; Krim M; Rubin BY; Hayward G
    Adv Exp Med Biol; 1985; 187():97-110. PubMed ID: 2412419
    [No Abstract]   [Full Text] [Related]  

  • 92. Quantitation and estimation of cooperation between target-binding sites in natural and antibody-dependent cell-mediated cytotoxicity by use of a mathematical transformation. Influence of interferon.
    Krebs HJ; Norrild B
    Scand J Immunol; 1983 Feb; 17(2):123-8. PubMed ID: 6836232
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Inhibition of lung colonization of mouse colon 26 adenocarcinoma by recombinant mouse interferon beta through a modification of platelet function.
    Tsuruo T; Saito H; Watanabe M; Sugimoto Y; Yamori T; Oh-Hara T
    Clin Exp Metastasis; 1990; 8(2):203-13. PubMed ID: 2317960
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Analysis of sequential substages of the natural killer cell lethal hit.
    Deem RL; Targan SR
    Adv Exp Med Biol; 1985; 184():239-56. PubMed ID: 3929573
    [No Abstract]   [Full Text] [Related]  

  • 95. [Effects of diethylstilbestrol diphosphate (DES-P) and alpha-interferon on natural killer cell activity in vitro].
    Ueno M; Marumo K; Muraki J; Baba S; Murai M; Tazaki H; Yamamoto Y
    Nihon Hinyokika Gakkai Zasshi; 1987 Oct; 78(10):1707-16. PubMed ID: 3444162
    [No Abstract]   [Full Text] [Related]  

  • 96. The enhancement of 5-fluorouracil anti-metabolic activity by leucovorin, menadione and alpha-tocopherol.
    Waxman S; Bruckner H
    Eur J Cancer Clin Oncol; 1982 Jul; 18(7):685-92. PubMed ID: 6982167
    [No Abstract]   [Full Text] [Related]  

  • 97. Modulation of apoptosis in human lymphocytes by adenosine analogues.
    Barbieri D; Franceschi C; Camaioni E; Costanzi S; Vittori S; Volpini R; Cristalli G
    Bioorg Med Chem Lett; 1998 Sep; 8(18):2533-8. PubMed ID: 9873575
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Cytotoxicity of 2-chlorodeoxyadenosine in a human tumor colony-forming assay.
    Hutton JJ; Von Hoff DD
    Cancer Drug Deliv; 1986; 3(2):115-22. PubMed ID: 2871921
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Combined effects of 5-fluorouracil and beta interferon on HBL-100 human breast cancer cells in vitro.
    Fuggetta MP; D'Atri S
    Pharmacol Res Commun; 1988 May; 20(5):439-40. PubMed ID: 3420152
    [No Abstract]   [Full Text] [Related]  

  • 100. Voltammetric behavior of mammalian tumor cells and bioanalytical applications in cell metabolism.
    Feng J; Ci YX; Lou JL; Zhang XQ
    Bioelectrochem Bioenerg; 1999 Feb; 48(1):217-22. PubMed ID: 10228590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.